ruxolitinib api

Ruxolitinib Phosphate (1092939-17-7) Ruxolitinib is an anti-tumor pharmaceutical agent indicated for the treatment of myeloproliferative neoplasm-associated myelofibrosis, polycythemia vera, and other myeloproliferative neoplasms, as well as refractory cancers. Product Specifications Product Name: Ruxolitinib Phosphate CAS No.: 1092939-17-7 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C17 H21 N6 O4 P Molecular Weight: 404.36 Shelf Life: 2 Years